House Appropriations OKs Bill Reversing FDA Abortion Pill Policy

The House Appropriations Committee on Wednesday approved 34-27 its bill funding the FDA in fiscal year 2024, including an attempt to walk back the agency’s updated safety program for the abortion pill mifepristone that went into effect in January.

If enacted, the measure would essentially curtail the use of mifepristone for medicated abortions, but it has little chance of making it into the Democratic-controlled Senate’s bill. Senate markups are slated to begin the week of June 19.

Earlier in the committee’s markup, Democratic appropriators decried the effort to repeal recent FDA changes to ...